An improved pediatric patient journey
Advanced diagnostics for complex conditions
Our unique tests, methodologies, and pediatric reference ranges provide accurate and fast results for complex pediatric gastroenterology conditions. Whether screening patients or monitoring therapeutic management, we cover the full spectrum of gastroenterology testing. We offer a robust menu of genetic tests to identify inherited disorders and provide insights about genetic variations associated with disease presence. Plus, our world-renowned Mayo Clinic gastroenterologists and genetic counselors can help you order tests and consult on the results.
We test for:
Inflammatory bowel disease
Unique to our lab, we offer the innovative TPNUQ test for thiopurine management. This test provides awareness of a patient's response to medications through genetic testing. We give insight to care teams by using census data and test analytics to assess potential risks in their patient population, helping to minimize disparities and improve pediatric diagnostic care.
Methodologies that make a big difference
We believe in methodologies that go far beyond the standard reference lab approach to pediatric testing. This includes sophisticated reflex testing that helps you determine if there's a clinical need for additional testing — while helping to reduce any unnecessary testing. Our methodologies also include rigorous spot checks to ensure accuracy and greater test sensitivity.
A test that changed a little boy's life
Due to complex symptoms, 8-year-old Hussein was misdiagnosed with IBD his entire life. But a test developed at Mayo Clinic Laboratories changed everything for Hussein and his family. Learn how this specific test could potentially change everything for one of your pediatric patients, too.
In this test specific episode of the "Answers From the Lab" podcast, Melissa Snyder, Ph.D., explains how IBDP2, when used after first-line testing has failed, can distinguish between ulcerative colitis and Crohn’s disease.
Ann Moyer, M.D., Ph.D., discusses TPNUQ, Mayo Clinic Laboratories' genotyping test for identifying patients at risk for thiopurine toxicity. Used prior to therapy initiation, our assay evaluates for nuances in both TPMT and NUDT15, which have associations to thiopurine metabolization.